InVasc Therapeutics, Inc. — Form D
InVasc Therapeutics, Inc. of TUCKER, GA, a company, filed a Form D exempt-offering notice with the SEC on 2010-07-13. The offering totals $12.0M, of which $3.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-07-13
- Form: D
- Accession: 0001496449-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $12.0M
- Amount sold: $3.2M
- Remaining: $8.8M
- Investors: 3
- Date of first sale: 2010-06-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-144812
Issuer
- Name: InVasc Therapeutics, Inc.
- CIK: 0001496449
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 3562 HABERSHAM AT NORTHLAKE, TUCKER, GA, 30084
- Phone: 678-736-5903
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Daniele D Cardoso | Director | Luxembourg L-150, N4 |
| Larry D Dillaha | Director | Tucker, GA |
| William D Johnston | Director | Kalamazoo, MI |
| William D Schaeffer | Director | Tucker, GA |
| William D Johnston | Executive Officer | Kalamazoo, MI |
| William D Schaeffer | Executive Officer | Tucker, GA |
More